
    
      To assess the efficacy and safety of the association of glucosamine sulphate 500
      mg/chondroitin sulphate 400 mg (Eurofarma) in the treatment of osteoarthritis, compared to
      CondroflexÂ® (Zodiac) in same presentation and pharmaceutical form.

      Some eligibility criteria:

      Osteoarthritis of the knee confirmed by radiological examination; Visual analogue scale (VAS)
      > 40 mm; Clinical diagnosis of pain and functional limitation
    
  